Telephone
64.9.869.3035
Address
64 Richard Pearse Drive Mangere, Auckland 2022
Description
Aroa Biosurgery Ltd. engages in the development, manufacturing, and marketing of soft tissue repair products. It focuses on healing for complex wounds, and soft tissue reconstruction procedures including abdominal wall reconstruction, breast reconstruction, and reconstructive surgery for trauma, limb salvage, and tumor resections. The company was founded by Brian Roderick Ward in 2008 and is headquartered in Mangere, New Zealand.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.63 - 1.25
Trade Value (12mth)
US$47,412.00
1 week
7.46%
1 month
-4.95%
YTD
-34.55%
1 year
-31.75%
All time high
1.745
EPS 3 yr Growth
-862.700%
EBITDA Margin
-14.10%
Operating Cashflow
-$12m
Free Cash Flow Return
-13.80%
ROIC
-10.10%
Interest Coverage
-4.90
Quick Ratio
11.30
Shares on Issue (Fully Dilluted)
359m
HALO Sector
Healthcare
Next Company Report Date
29-May-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
NZD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 23 |
September 2023 Quarterly Report and Appendix 4C
×
September 2023 Quarterly Report and Appendix 4C |
31 October 23 |
Investor Presentation
×
Investor Presentation |
31 October 22 |
Change of Registry Address
×
Change of Registry Address |
31 May 23 |
FY23 Appendix 4E and Full Year Results
×
FY23 Appendix 4E and Full Year Results |
31 May 23 |
FY23 Full Year Results Presentation
×
FY23 Full Year Results Presentation |
31 March 23 |
Notification regarding unquoted securities - ARX
×
Notification regarding unquoted securities - ARX |
31 March 23 |
Change of Director's Interest Notice - JD
×
Change of Director's Interest Notice - JD |
31 March 23 |
Change of Director's Interest Notice - PM
×
Change of Director's Interest Notice - PM |
31 March 23 |
Change of Director's Interest Notice - BW
×
Change of Director's Interest Notice - BW |
31 March 23 |
Change of Director's Interest Notice - JM
×
Change of Director's Interest Notice - JM |
31 March 23 |
Change of Director's Interest Notice - JP
×
Change of Director's Interest Notice - JP |
31 March 23 |
Change of Director's Interest Notice - SE
×
Change of Director's Interest Notice - SE |
31 July 23 |
June 2023 Quarterly Report and Appendix 4C
×
June 2023 Quarterly Report and Appendix 4C |
31 January 23 |
December 2022 Quarterly Report and Appendix 4C
×
December 2022 Quarterly Report and Appendix 4C |
31 January 23 |
Investor Presentation
×
Investor Presentation |
31 August 23 |
Section 708A Notice
×
Section 708A Notice |
31 August 23 |
Application for quotation of securities - ARX
×
Application for quotation of securities - ARX |
31 August 23 |
Notification of cessation of securities - ARX
×
Notification of cessation of securities - ARX |
30 June 23 |
Annual Report to Shareholders
×
Annual Report to Shareholders |
30 June 23 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
30 June 22 |
Annual Report to Shareholders
×
Annual Report to Shareholders |
30 June 22 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
30 July 20 |
Investor Presentation - July 2020
×
Investor Presentation - July 2020 |
29 November 22 |
Appendix 4D and Half Year Report
×
Appendix 4D and Half Year Report |
29 November 22 |
Aroa Biosurgery Half Yearly Results H1 FY23
×
Aroa Biosurgery Half Yearly Results H1 FY23 |
29 November 22 |
Aroa Half Year Results Presentation
×
Aroa Half Year Results Presentation |
29 July 21 |
Investor Presentation
×
Investor Presentation |
29 April 22 |
AROA BIOSURGERY TO PRESENT AT NWR VIRTUAL CONFERENCE
×
AROA BIOSURGERY TO PRESENT AT NWR VIRTUAL CONFERENCE |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.